BioCardia Inc. (NASDAQ: BCDA) announced its timeline for seeking regulatory approvals for its CardiAMP Cell Therapy System and Helix Transendocardial ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE